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Background
Papillary thyroid carcinoma (PTC) is one of the most com-
mon cancer types in the Middle East and North African
(MENA) region and more abundant than in many other
world regions suggesting that genetic susceptibility factors
for this malignancy are likely to vary between the popula-
tions studied. We assessed in a population from the
MENA region the allele frequencies of two SNPs which
may bear the capacity to confer risk for developing PTC.
SNP rs2910164 is a sequence polymorphism in the precur-
sor microRNA (mir)146a. The heterozygous C/G state of
rs2910164 was found to be associated with a reduced
amount of mir146a which in turn had an effect on the effi-
ciency to inhibit target genes as CCDC6 [1,2]. SNP
rs1867277 is located 283 bp upstream of the translational
start site of the developmental gene encoding forkhead
box E1 (FOXE1) and identified as an associated risk fac-
tors for a number of solid tumors including PTC [3,4].
Materials and methods
SNPs rs2910164 and rs1867277 were investigated in
patients with PTC and volunteers without a thyroid dis-
ease (case and control group each, N=207-234) using
PCR, including a multiplex PCR step on genomic DNA,
to amplify each SNP region. PCR products were directly
sequenced. For Hardy-Weinberg (HW) equilibrium test-
ing the Online Encyclopedia for Genetic Epidemiology
studies (http://www.oege.org) was used. Odds ratios
(ORs) and 95% confidence intervals (CI) were calculated
using the online VassarStats website for statistical com-
putation (http://vassarstats.net/index.html) and consid-
ered to be statistically significant for a P-value < 0.05.
Results
Both SNPs rs2910164 (mir146a) and rs1867277 (FOXE1)
were in HW disequilibrium in the patient group (X2 =
8.33 and X2 = 8.29, respectively) but in equilibrium in
the control group (X2 = 0.87 and X2 = 1.56, respec-
tively). For rs2910164 a trend association with PTC was
found for the heterozygous C/G state when compared
to the combined C/C+G/G states (OR = 0.51, CI 0.51-
1.1, P = 0.11). For rs1867277 the risk allele A was signif-
icantly associated with PTC in comparison to allele
G (OR = 1.94, CI 1.48-2.53, P < 0.0001).
Conclusions
The HW disequilibrium of SNP rs1867277 in the PTC
group and its significant association of risk allele A with
PTC let us suggest that this SNP in the developmental
FOXE1 gene may represent an additive risk factor for
developing PTC in the investigated population.
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